[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
January 2005

Sentinel Lymph Node Biopsy in Recessive Dystrophic Epidermolysis Bullosa and Squamous Cell Carcinoma

Arch Dermatol. 2005;141(1):110-111. doi:10.1001/archderm.141.1.110

Squamous cell carcinoma (SCC) is the most common cause of death in patients with recessive dystrophic epidermolysis bullosa (RDEB).1 In the Hallopeau-Siemens type, the cumulative risk is 76.5% by age 60 years.2 The sentinel lymph node (SLN) biopsy technique enables the early detection of micrometastasis not only in melanoma but also in other skin malignancies such as high-risk SCC or Merkel cell carcinoma.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×